Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2024-03-26 Capital/Financing Update
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Ajooni Biotech Limited to the National Stock Exchange of India regarding the outcome of a Rights Issue Committee meeting. It details the revision of the record date and the schedule for the Rights Issue, including issue opening and closing dates, issue price, and terms of payment. The document references compliance with SEBI Listing Regulations and provides specifics about the rights issue shares and timeline. There are no financial statements or detailed financial performance data present, nor is this a report or presentation. The content is an update on a capital raising activity (rights issue), which fits the category of Capital/Financing Update (CAP). The document length is about 4730 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-03-26 English
Revised Record date
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India Limited regarding a change in the record date for a rights issue. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content focuses on updating shareholders and the exchange about the revised record date for determining shareholders entitled to receive rights entitlements. There are no financial statements, detailed financial data, or comprehensive reports included. The document is short (1418 characters) and serves as an announcement of a capital market event (rights issue record date change). This fits the category of Capital/Financing Update (CAP) rather than a full report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2024-03-26 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Ajooni Biotech Limited to the National Stock Exchange of India regarding the outcome of a Rights Issue Committee meeting. It details the revision of the record date and the schedule for the rights issue of equity shares, including issue price, size, ratio, and terms of payment. The document references SEBI Listing Regulations and provides specifics about the rights issue but does not contain financial statements or comprehensive financial analysis. It is an update on capital raising activity, specifically a rights issue, which fits the category of Capital/Financing Update (CAP). The document length is 4653 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is CAP with high confidence.
2024-03-26 English
Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication from Ajooni Biotech Limited to the National Stock Exchange of India regarding the record date and schedule for a Rights Issue of equity shares. It references Regulation 30 and 42 of the SEBI Listing Regulations, which pertain to disclosure obligations for listed companies. The content details the terms, issue size, price, and timeline for the Rights Issue but does not contain financial statements or results. It is an update on capital raising activity, specifically a rights issue, which fits the category of Capital/Financing Update (CAP). The document length is about 5,000 characters and is a formal announcement rather than a full report or financial statement. Therefore, the appropriate classification is CAP with high confidence.
2024-03-22 English
Record Date
Capital/Financing Update Classification · 100% confidence The document is an official communication addressed to the National Stock Exchange of India regarding the record date and schedule for a Rights Issue of equity shares by Ajooni Biotech Limited. It details the terms of the Rights Issue, including issue size, price, ratio, and payment terms. The document references compliance with SEBI Listing Regulations and is an announcement of a capital raising event through a rights issue. It does not contain financial statements or detailed financial performance data but rather informs about the capital issuance process and related dates. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and is not a report publication announcement or certification, but a substantive update on financing activity.
2024-03-22 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India regarding the outcome of a Rights Issue Committee meeting. It details the approval of a rights issue of equity shares, the fixing of a record date for shareholders eligible to apply, and the schedule for the rights issue opening and closing dates. The document references compliance with SEBI Listing Regulations and SEBI ICDR Regulations, indicating it is an official announcement related to capital raising activities. The content focuses on the update about the company's financing activity rather than a full financial report or other types of filings. The document length is 3036 characters, which is relatively short and consistent with an announcement rather than a detailed report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-03-22 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.